Long-Term Use of Intravitreal Bevacizumab (Avastin) for the Treatment of Von Hippel-Lindau Associated Retinal Hemangioblastomas

Fig. (1) Fundus Photographs and Fluorescein Angiograms at 0, 24, and 60 months.